Source: International Congress 2018 – Novel drug targets for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pisano (Parma, Italy), D. Miglietta (Parma, Italy), F. Bignami (Parma, Italy), A. Allen (Parma, Italy), M. Biagetti (Parma, Italy), G. Aquino (Parma, Italy), C. Carnini (Parma, Italy), M. Civelli (Parma, Italy), G. Villetti (Parma, Italy). Anti-inflammatory effects of the JAK inhibitor tofacitinib in two murine house dust mite -driven models of asthma.. 1941

Member's Comments

No comment yet.

Related content which might interest you: Involvement of apoptosis signal-regulating kinase-1 in house dust mite-induced allergic asthma in mice Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Profiling the impact of two JAK inhibitors in a pre-clinical model of allergic asthma Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005 The effect of montelukast during allergen sensitization period in house dust mite mouse model Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Source: Eur Respir J 2010; 35: 1377-1387 Year: 2010 Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Local lung house dust mite (HDM) challenges induce cell necrosis in mouse experimental asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Effects of 3-yr immunotherapy with standardised extracts of house dust mite in allergic asthmatic subjects receiving appropriate drug treatment Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002 Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 A novel house dust mite-induced asthma model in guinea pigs driven by mast cells Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Models to mimic allergic asthma using house dust mite or Aspergillus fumigatus in mice: advantages and disadvantages Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005